Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hookipa Pharma Inc (NQ: HOOK ) 6.470 -0.020 (-0.31%) Streaming Delayed Price Updated: 9:31 AM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,249 Open 6.450 Bid (Size) 6.300 (7) Ask (Size) 6.460 (1) Prev. Close 6.490 Today's Range 6.450 - 6.470 52wk Range 0.4100 - 6.770 Shares Outstanding 21,588,756 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why HOOKIPA Pharma (HOOK) Stock Is Volatile Today July 08, 2024 HOOKIPA Pharma shares are trading lower by 10.9% during Monday's session. The company announced a 1-for-10 reverse stock split. Via Benzinga HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split July 08, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire Performance YTD +679.51% +679.51% 1 Month +806.78% +806.78% 3 Month +748.51% +748.51% 6 Month +825.20% +825.20% 1 Year +626.96% +626.96% More News Read More HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV July 01, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday June 05, 2024 Via Benzinga Deep Dive Into HOOKIPA Pharma Stock: Analyst Perspectives (4 Ratings) May 21, 2024 Via Benzinga Breaking Down HOOKIPA Pharma: 4 Analysts Share Their Views April 26, 2024 Via Benzinga HOOKIPA Pharma: Q4 Earnings Insights March 22, 2024 Via Benzinga HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting June 04, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting May 30, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session May 27, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 24, 2024 Via Benzinga HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting May 23, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch May 16, 2024 Via InvestorPlace HOOK Stock Earnings: HOOKIPA Pharma Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 Via InvestorPlace HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights May 09, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire Stocks Creating Buzz Look Now: VTAK, AMST, HOOK, MULN, KAVL April 26, 2024 Via AB Newswire Topics Artificial Intelligence Exposures Artificial Intelligence HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab April 25, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday? April 24, 2024 Via Benzinga Exposures Product Safety HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers April 24, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4) April 16, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients April 15, 2024 Via Benzinga HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration April 10, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Beats Revenue for Q4 2023 March 22, 2024 Via InvestorPlace HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights March 22, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference March 06, 2024 From HOOKIPA Pharma Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
